Given the paramount role that CaMKII activation plays in multiple cardiac disease pathways and the established significance for βIV-spectrin in regulating cardiac fibrosis, the βIV-spectrin/CaMKII axis represents a comprehensive event and attractive therapeutic candidate in fibrotic remodeling. This evidence concerns the gene CAMK2G and heart disorder.